Building Image Background
Sharan Nirmul profile photo

Sharan Nirmul

Partner

D  484.270.1465
F  610.667.7056

Sharan Nirmul represents a number of the world’s largest institutional investors in cutting edge, high stakes complex litigation.

Among his representative cases, Mr. Nirmul served as lead counsel in a multi-district litigation against BNY Mellon for the excess spreads it charged to its custodial customers for automated FX services. Litigated over four years, involving 128 depositions and millions of pages of document discovery, and with unprecedented collaboration with the U.S. DOJ and the New York AG, the litigation resulted in a settlement for the Bank’s custodial customers of $504 million. Mr. Nirmul also spearheaded litigation against the nation’s largest ADR programs, Citibank, BNY Mellon and JP Morgan, which alleged they charged hidden FX fees for conversion of ADR dividends. The litigation resulted in $100 million in recoveries for ADR holders and significant reforms in the FX practices for ADRs. In Transatlantic Re v. A.I.G., Mr. Nirmul recovered $70 million for Transatlantic Re in a AAA arbitration against its former parent, American International Group, arising out of AIG’s mismanagement of a securities lending program.

Mr. Nirmul has served as lead counsel in several high-profile securities fraud cases. Most recently, he served as lead counsel in the securities fraud case involving General Electric and its GE Power division, which resolved in November 2024, a month before a jury trial was set to begin for $365.5 million. He also served as lead counsel in a matter involving Wells Fargo’s sham hiring practices, which resolved in November 2025 for $86 million. Most recently, Mr. Nirmul, resolved claims against Rivian and its underwriters arising out of its November 2021 IPO for $250 million. Some other recent highlights include:

  • $450 million recovery for Kraft Heinz shareholders arising from the botched merger between Kraft and Heinz.
  • $187.5 million recovery for Snap investors arising from misstatements in its IPO disclosures.
  • $185 million recovery for Luckin Coffee shareholders arising from accounting fraud related to its IPO.
  • $80.5 million recovery for Endo Pharmaceuticals shareholders arising from disclosures concerning the efficacy of its opioid drug, Opana ER.

Speaking Engagements

Sharan is a regular speaker at the Firm’s annual conferences, the Rights & Responsibilities of Institutional Investors in Amsterdam and the Evolving Fiduciary Obligations of Pension Plans in Washington, D.C.

Awards/Rankings

  • Benchmark Litigation Star, 2020-2025
  • Lawdragon 500 Leading Plaintiff Financial Lawyer, 2019-2026
  • Philadelphia Business Journal’s Best of the Bar 2023
  • National Law Journal Trailblazers Plaintiffs’ Lawyers, 2021
  • Lewis Memorial Award, George Washington National Law Center, 2001, for excellence in clinical practice

Best of the bar badge - Sharan Nirmul Lawdragon 500 Leading Plaintiff Financial Lawyers 2025 award

Practice Areas

Education

  • Cornell University
    B.S.
  • New College, Oxford University
    Joint Programme in International Human Rights Law
  • The George Washington University Law School
    J.D.

Admissions

  • Pennsylvania
  • New Jersey
  • New York
  • Delaware
  • USDC, Southern District of New York
  • USDC, Eastern District of New York
  • USDC, District of New Jersey
  • USDC, District of Delaware
  • USDC, Eastern District of Pennsylvania
  • USCA, Second Circuit
  • USCA, Third Circuit
  • USCA, Seventh Circuit
Scroll to Top